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Abstract
Objectives: This paper explores the use of evidence, focusing on economic evidence in particular, in
the development of local health policies through an in-depth study of Health Improvement Programmes
(HImPs) in England.
Methods: A questionnaire was sent to the person responsible for coordinating the development of the
HImP in each of the 102 English health authorities. In addition, semi-structured interviews were con-
ducted with 10 HImP leaders, and a random sample of 26 HImP documents was reviewed using a
standard pro forma.
Results: Of the 102 mail questionnaires sent out, 68 (67%) were returned. It was found that those
developing HImPs had multiple objectives, only some of which (e.g., efficiency in healthcare provision)
would necessarily require evidence. Where evidence was used, this was a mixture of internal (experien-
tial) and external (empirical) evidence, with the balance (66%) being in favor of the latter. Government
reports and guidance from the National Institute for Clinical Excellence (NICE), were the main sources
of external evidence, rather than published papers. Key barriers to the use of economic evidence were
lack of time and availability and the difficulties in synthesizing information at the local level.
Conclusions: Based on responses to our survey, the main ways of increasing the use of evidence in the
development of local health policies in England are to produce more evidence-based national guidance
and to produce accessible summaries of the available literature for local decision makers.
Keywords: Evidence, Decision making, Health technology assessment, Health policy
In many countries the investment in health services research and health technology assess-
ment (HTA) is now quite extensive, and HTA agencies exist in a number of jurisdictions.
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While improvements could still be made to the range, quality, and timeliness of evidence on
the effectiveness and cost-effectiveness of healthcare treatments and technologies, issues
surrounding the production of evidence are largely understood.
In contrast, the consumption or use of evidence in healthcare decision making is much
less understood and, in general, insufficient. Recently Dobbins et al. (2) examined the
influence of five systematic reviews on public health decisions and explored which factors
were associated with influencing those decisions. Based on public health decision makers’
perceptions, it was found that the reviews had most influence on decisions relating to
program planning and program justification, while the reviews were perceived to have least
influence on program evaluation decisions. Such research is few and far between. A number
of surveys of healthcare decision-makers indicate that the use of HTA evidence by health-
care decision makers is sparse (7). Several authors have discussed the barriers to the use of
evidence and how they may be overcome (3;12).
Within Europe, the most extensive studies of the dissemination and use of HTA evi-
dence have been carried out as part of the EUR-ASSESS project (6) and its successor, the
ECHTA/ECAHI project (Henshall C, Koch P, et al. HTA in policy and practice: To identify
and share successful approaches to link findings of assessments, and their contribution to
health indicators, to healthcare decision making. ECHTA/ECAHI. June 2001, unpublished).
The general conclusion is that the majority of research into dissemination and use of evi-
dence has focused on clinical practitioners, and much less is known about the use of HTA
in health policy development, particularly at the local level.
Indeed, Henshall et al. (unpublished) pointed out that much of the information required
to explore the use of HTA information is not published in academic papers, but in “Federal
registers and gazzettes, which are not part of the traditional academic databases such as
Medline and Embase.” They recommended that further in-depth research is required on the
structure of European healthcare systems with respect to their decision-making anatomy in
order to identify decision nodes where HTA can contribute relevant information.
This paper explores the use of evidence in the development of local health policies
through an in-depth study of Health Improvement Programmes (HImPs) in the United
Kingdom (more precisely, England). The concept of the HImP was introduced in a gov-
ernment white paper in 1997 (10) and was described as “an action programme led by the
health authority to improve the health and healthcare locally” (19). There are three stated
aims of the HImP: a) to provide a framework for health and social care through interagency
collaboration; b) to produce action plans based on evidence to address local and national
priorities; and c) to make a healthcare program that involved, and was accessible to, the
public.
The HImP formed an excellent vehicle for the study of the use of evidence at the
local level because its production was a statutory requirement for all health authorities and
local plans were expected to be based on evidence. Additionally, given recent large-scale
investments in health services research and development in the United Kingdom and the
efforts to issue guidance to the National Health Service (NHS) through National Service
Frameworks (NSFs) (9;10) and the National Institute for Clinical Excellence (NICE) (11),
the environment for consideration of evidence in local policy development is currently
extremely favorable.
METHODS
The study, which was funded by the Department of Health in England, considers the second
phase of HImPs, which covers the period from 2000–03. There were three components to the
research. First, a mail questionnaire was sent to the person responsible for coordinating the
development of the HImP in each of the 102 health authorities in England. The background
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of respondents varied, but the majority had a background in public health. The questionnaire
(available from the authors) asked about the objectives of the HImP, the staff involved in its
production, the sources and types of evidence used, and the barriers to the use of evidence.
Additionally, examples of the use of evidence were sought, with a particular emphasis on
economic evidence. Some questions addressed the production of the HImP as a whole,
whereas some more specific ones addressed two program areas that had to be covered in all
authorities’ HImPs: cancer and coronary heart disease.
Second, a sample of 10 respondents, who indicated in the questionnaire that they would
be willing to participate in a semi-structured telephone survey, were contacted. Respondents
were chosen for interview either: a) because they raised interesting issues in their responses
to the open-ended questions in the postal questionnaire; or b) because their responses raised
issues about the use of economic evidence that we wished to explore. The interviews were
used to obtain more detailed information on respondents’ thoughts on the role of evidence
in HImPs, to explore themes emerging from the preliminary analysis of the postal survey,
and to follow-up any examples of interesting local initiatives in the use of evidence.
Third, a random sample of 26 (25%) of the written HImP documents were analyzed
using a standard pro forma in order to assess the extent to which these recognized the role of
evidence or cited examples of evidence that had been used. While this last component of the
research provided some verification of the responses obtained from the mail questionnaire
and interviews, this was only partial. The written HImP documents, which averaged around
100 pages long, were merely the summary of an extensive process. In order to verify the
questionnaire responses fully, it would be necessary to review every background paper,
every set of meeting minutes, and possibly even attend every meeting as an observer.
Throughout the study, an important distinction was made between two types of evi-
dence: a) internal (experiential) evidence, based on professional opinion and tacit knowl-
edge; and b) external (empirical) evidence, based on research from primary or secondary
studies, published papers, or guidelines (1). In practice the distinction between internal and
external evidence might merge because, for example, professional opinion might be based
on published sources of evidence. However, this definition of evidence enabled us to as-
sess the relative emphasis placed on different types of evidence and to identify the specific
contribution of published sources (e.g., HTA agency reports).
RESULTS
Response to the Mail Questionnaire
Of the 102 mail questionnaires sent out, 68 were returned, giving a response rate of 67%.
The response rate was relatively uniform by geographical area and was similar to that
achieved in a number of other postal questionnaires sent to healthcare decision makers in
the United Kingdom (5;8). The majority of respondents worked in public health depart-
ments and were medically trained. Others worked in a variety of departments (e.g., health
promotion, planning, and corporate affairs) and were trained in a range of other disciplines
(e.g., statistics, economics, operational research, management studies, and accountancy).
Questionnaire results are provided below.
Although we have no details of the views of those that did not respond, it would be
conservative to assume that nonrespondents are less optimistic about the use of evidence
than those who did respond.
The Objectives of HImPs
It was important to explore respondents’ perceptions on the objectives of HImPs, since
these may condition their views on the value of various types of evidence. The responses
are given in Figure 1.
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Figure 1. Objectives of HImPs.
It can be seen that the most important perceived objectives were to improve health,
to reduce health inequality, and to encourage partnership in the provision of health care.
By contrast, a focus on efficient provision of care was rated as somewhat less important.
The high ratings of health improvement and reduction of health inequality are unsurprising.
However, the high rating given to encouraging partnership emphasizes the point that decision
makers often like to see an inclusive process for making decisions, which means that some
individuals might have influence over decisions, whether they refer to evidence or not.
Balance of Internal and External Evidence
It was recognized at the outset that the decision-making process draws on a number of
sources of information and not just published data. Figure 2 shows the balance of different
types of evidence used in the development of HImPs. It can be seen that most respondents
felt that a mixture of internal and external evidence was used, with the emphasis being on
the use of external evidence. As with other responses, this answer could reflect what the
respondents think they should be doing, rather than what they actually do. However, in
response to a latter part of the questionnaire, some respondents did provide actual examples
of the use of external evidence.
Sources of Evidence
The perceived importance of various sources of external evidence is given in Figure 3. The
most striking finding is the high reliance placed on official government sources, such as
NSF guidelines, government publications, and NICE guidance. This probably reflects both
the perceived quality of the documents themselves and the fact that, within the English
NHS, considerable emphasis is currently being placed on performance management; that
is, health authorities have to ensure that various targets in health or healthcare provision are
met. Many such targets are embodied in the national guidance, for example, the NSF on
coronary heart disease (CHD) (10).
In addition, it can be seen that various traditional published sources of evidence were
considered to be of some importance, although not as important as the government guidance.
Of the published sources, the secondary sources (i.e., publications giving easily accessible
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Figure 2. Balance of internal evidence and external evidence.
Figure 3. Sources of external evidence.
summaries of the relevant literature) were ranked the highest. Finally, it can be seen that
specially commissioned work, from academic researchers or management consultants, was
not considered very important. This might reflect the lack of time or money available to
commission such research at the local level.
Figure 4 gives details of the perceived importance of various sources of internal evi-
dence. Clinical opinion was thought be the most important source of internal evidence, and
it is therefore important that their opinions be as evidence based as possible.
Role and Use of Economic Evidence
Several previous surveys have suggested that the use of economic evidence in health-
care decision making presents a particular challenge, either because decision makers do
not understand it or are uncomfortable about embracing the cost-effectiveness criterion
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Figure 4. Sources of internal evidence.
Figure 5. Should economic evidence influence the design of HImPs?
(4;7). Therefore, some of the survey questions focused on the use of economic evidence in
particular.
Figure 5 shows that, at least for this group of respondents, economic evidence was
considered highly relevant. Indeed, there was a widespread understanding that economics
was not about cutting costs but about maximizing the benefits in improved health from
the resources available. For those respondents who felt that economic evidence was only
marginally relevant, the main concerns were practical ones, rather than issues of principle
(for example, lack of access to economic expertise at the local level).
Figure 6 indicates the relative usefulness of various types of economic evidence. The
results confirm the importance, as perceived by local decision makers, of secondary sources
(e.g., reviews) and advice from government bodies such as NICE. The importance of
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Figure 6. Use of economic evidence.
Figure 7. Barriers to use of economic evidence.
discussion and advice from economists was not ranked very highly, perhaps because few
health authorities had access to such advice.
Barriers to the Use of Evidence
Respondents were asked to identify the main barriers to the use of evidence (both internal
and external) in the design of their HImP. Figure 7 reveals no clear prominence of one
reason over another, although only 13% of respondents felt that they had enough time to
look for the relevant evidence.
Additional Insights from the Telephone Interviews
The telephone interviews confirmed many of the findings of the main questionnaire, in
particular the extensive reliance placed on national guidance, such as that contained in the
NSFs. One important factor was the lack of time and other resources at the local level to
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gather and interpret evidence. This meant that evidence was often used in a reactive way to
support current policies, rather than in a proactive way to help develop new policies.
The other main insight from the telephone interviews was that most respondents inter-
preted the role of the HImP very broadly. This had two implications for the use of evidence.
First, respondents interpreted the definition of health improving measures to include so-
cioeconomic determinants as well as purely medical ones. However, there was a dearth
of evidence about these broader determinants and associated interventions, except in ar-
eas such as smoking cessation programs. Second, the role of the HImP was considered
to include developing partnerships with other agencies and the involvement of the general
public. These objectives could be achieved without the use of evidence per se.
Main Findings from the Review of HImP Documents
The review of HImP documents showed that, apart from the three program areas that had to
be included (cancer, CHD, and mental health), an average number of nine other programs
or areas were featured in HImPs. These included areas such as services for children and
young people, drugs and substance misuse, services for people with learning and physical
difficulties, and accidents.
There was quite extensive reference to national guidance in the documents, in line
with the findings of the mail questionnaire and telephone interviews. For example, 92%
of the HImP documents reviewed for the use of CHD evidence referred to the NSF on
CHD. Beyond this there was only occasional reference to the use of other types of external
evidence, although, as was pointed out earlier, this is more likely to be found in supporting
documents than the HImP itself.
Around two-thirds of HImP documents referred to economic considerations in their
introduction, although only 2 of the 26 HImPs reviewed mentioned cost-effectiveness ex-
plicitly. Only one HImP in the sample mentioned any specific cost-effectiveness evidence.
DISCUSSION
The aim of this research was to investigate the role of evidence, particularly economic
evidence, in the development of local health policies. It has been recognized that, at the
time of the study, HImPs were only in their second year. Also, it must be recognized that
surveys have inherent weaknesses, in that respondents may give the answers they feel
they should give, rather than answers reflecting reality. Therefore, an analysis of HImP
documents was also undertaken. Bearing this in mind, the main themes emerging from the
research were as follows:
1. Local health policies are seen as having multiple objectives. Whereas the improvement of the
health of the population is viewed as the prime objective of HImPs, other important objectives
are to reduce health inequalities and to develop partnerships. For many local policy makers, the
process of developing HImPs was as important as the outcome, particularly since HImPs are in
their infancy. Therefore, we might expect to see a trend toward more measurable targets and the
more explicit use of evidence in the future.
Many respondents, particularly those from a public health background, saw the process of
developing HImPs as a way of stressing the broader socioeconomic determinants of health, as
opposed to the “medical model” of health and health care. However, some of their efforts to
stress broader socioeconomic interventions to improve health were thwarted by the relative lack
of evidence on costs and effects of such interventions.
2. The notion of evidence is interpreted broadly. It is clear from the research that traditional notions
of evidence, namely data drawn from classical research studies and published in the literature, do
not encompass the range of inputs to the design of an HImP. Many of the inputs relate to national
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guidance and local professional opinion, which in turn might be based on data from research studies.
Therefore, it is important to have a broad definition of what constitutes evidence. The distinction
used here, between internal and external evidence, proved useful in exploring respondents’ views
on the use of evidence in developing HImPs.
3. Basic concepts of economics are well understood if not always applied. Most respondents were
clear as to the basic principles of economics and the need to make choices when faced with a budget
constraint. However, the level of access to economic analyses and economics expertise was low.
Therefore, even where economic studies did exist, it was not clear how they could be interpreted
and used. More importantly, given the various constraints operating locally, most respondents
found it difficult to operationalize economic concepts in decision making, even if they wished to
do so.
4. Local constraints greatly influence the development of policies. Most respondents commented on
the speed at which their HImP had to be developed and that time limitations precluded extensive
searches for evidence. In addition, several key resources were not available, or in a limited supply, at
the local level. This made it impossible to search for, synthesize, and interpret evidence, particularly
economic evidence. Economic evidence had the additional problem that it might not transfer easily
from one setting to another, in contrast to evidence on the effectiveness of interventions. Therefore,
it needed extra interpretation in light of the local context.
Political acceptability is also an important criterion in judging healthcare interventions at the
local level. Therefore, external evidence is often merged with local professional and public opinion
when deciding upon priorities, since the evidence will be discussed locally prior to reaching a
decision.
5. National guidance is very influential in the design of local health policies. It was clear from the
responses that most health authorities took very seriously the guidance embodied in the NSFs and
(more recently) pronouncements from NICE. Respondents assumed that the evidence base of such
guidance was sound, although the guidance itself may not always have high relevance, given local
circumstances. In particular, health authorities wanted more advice on how to implement NICE
guidance locally.
Given the constraints, in time and expertise at the local level, central initiatives are therefore
critical to the local policy process. These include not only the issuing of guidance through NICE and
the NSFs, but also initiatives in the generation, synthesis, and dissemination of evidence through
the Health Technology Assessment (HTA) Programme, the Cochrane Collaboration, and bodies
such as the NHS Centre for Reviews and Dissemination.
CONCLUSIONS
Based on responses to our survey, the main ways of increasing the use of evidence in
the development of local health policies in England are to produce more evidence-based
national guidance and to produce accessible summaries of the available literature for local
decision makers.
POLICY IMPLICATIONS
The results of this research suggest a number of policy initiatives. Some are already un-
derway in the U.K. National Health Service, others could be considered. Some of the
suggestions may also be relevant in other national health services where local authorities
have autonomy, but where there is considerable guidance from the Ministry of Health.
First, the evidence base of national guidance should be maintained, if not strengthened,
while at the same time leaving scope for local interpretation. Given local constraints on
time and resources, those developing local policies are only too willing to embrace national
guidance. Therefore, this represents the major vehicle for improving the evidence base
of local decisions. It is important, therefore, that the evidence base of national guidance
remains strong and that it embraces some economics principles.
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Second, efforts should continue to generate, synthesize, and disseminate evidence on
a national level. Only on rare occasions will there be opportunities to undertake a com-
prehensive review of the evidence at the local level. Therefore, in the United Kingdom the
considerable efforts already made to generate, synthesize, and disseminate evidence through
the NHS R&D Programme are critical to improving the evidence base of local decisions.
Those developing local policies were particularly appreciative of readily accessible reviews
of cost-effectiveness evidence and were less likely to consult academic journals containing
the original studies.
The synthesis and dissemination of economic evidence presents some particular chal-
lenges, since local factors might influence whether a particular intervention is cost effective.
Thus, the interpretation of economic evidence from another setting can pose difficulties.
Therefore, more effort should be placed on understanding how local factors influence cost-
effectiveness and the ways in which local decision makers can better interpret economic
study results in their own circumstances.
Third, quantifiable targets (for health improvement) and the role of evidence in priority
setting and target setting need to be stressed. Many respondents acknowledged that, as the
learning curve in producing local health policies was climbed, there would be less emphasis
on process issues and more on outcomes. They also felt that evidence would be used more
explicitly. The policies differed greatly in terms of their emphasis on quantifiable targets
and mechanisms to consider evidence in a formalized manner. Some of the more promising
local initiatives, such as the use of pro formas or cost-benefit matrices, should be studied
further to ascertain whether they could be more widely adopted.
Fourth, the local role in assembling evidence needs to be clearly defined and adequately
resourced. While most of the teams developing local health policies relied on national
guidance, such guidance clearly needs to be interpreted in the light of local circumstances.
Therefore, a clearer specification is required of the local demographic, epidemiologic, and
financial information necessary to produce local policies, along with guidance on how
this information can be accessed. However, the responses to the questions about resources
indicated some were in short supply, in particular economics expertise.
Fifth, efforts to educate healthcare professionals in evidence-based medicine and eco-
nomics should be maintained or strengthened. It was clear from the surveys that local profes-
sional opinion, especially clinical opinion, is central to the production of local health policies
and the development of priorities. This emphasis will remain, even if the efforts outlined
above—to strengthen the evidence base of national guidance and to disseminate evidence—
are made. Therefore, it is important that, through educational programs, clinicians have an
adequate appreciation of the principles of evidence-based medicine and economics. This
will maximize the possibility that their opinions, when given, will embody these principles.
Sixth, more research should be undertaken into the cost-effectiveness of broader socio-
economic interventions to improve health. Several respondents talked about the tension
between the socioeconomic and medical models of health and the fact that, in assigning pri-
orities, medical interventions had precedence due to their superior evidence base. Therefore,
more attention should be placed on evaluating some of the broader interagency interventions
that were identified as part of the process of developing local health policies.
Finally, the impact of broader organizational changes on the development of local health
policies needs to be recognized. In the United Kingdom the current health authorities will
soon cease to exist. Instead, new strategic health authorities will be created, covering much
larger populations. In parallel with this, the primary care trusts (PCTs) will play a much
greater role in the development of local health policies and priorities.
The major issue raised by these organizational changes, in relation to this study, is
whether PCTs will have the level of resource and expertise to gather, synthesize, and
interpret evidence. In particular, they may not have very extensive skills in public health or
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economics. This study showed that such resources were often in limited supply, or absent,
in health authorities.
As the details of the current organization changes are finalized, some of these issues
will need to be addressed. In the meantime, however, PCTs are likely to be even more
reliant on the national guidance than were the health authorities in our survey. This suggests
that many of the policy implications identified above have even more relevance, given the
organizational changes that are about to take place.
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